Gracure Pharmaceuticals Limited — Folic Exporter Profile
Indian Pharmaceutical Exporter · #2 for Folic · $3.0M export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #2 Indian exporter of Folic with $3.0M in export value and 236 verified shipments. Gracure Pharmaceuticals Limited holds a 5.3% market share in Folic exports across 3 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Folic Export Profile: Buyers & Destinations
Where Does Gracure Pharmaceuticals Limited Export Folic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $2.9M | 231 | 98.2% |
| GERMANY | $44.3K | 3 | 1.5% |
| TANZANIA | $8.8K | 2 | 0.3% |
Gracure Pharmaceuticals Limited exports Folic to 3 countries. The largest destination is BELGIUM accounting for 98.2% of Gracure Pharmaceuticals Limited's Folic shipments, followed by GERMANY (1.5%) and TANZANIA (0.3%). These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Folic from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EXPHAR SANIVELLES SUD ZONE II THINES | BELGIUM | $315.1K | 20 |
| PHILCO PHARMA E.K., | GERMANY | $29.6K | 2 |
| PHILCO PHARMA E K | GERMANY | $14.7K | 1 |
| H H PHARMA LTD RWANDA | TANZANIA | $8.8K | 2 |
Gracure Pharmaceuticals Limited supplies Folic to 4 buyers globally. The largest buyer is EXPHAR SANIVELLES SUD ZONE II THINES (BELGIUM), followed by PHILCO PHARMA E.K., (GERMANY) and PHILCO PHARMA E K (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Folic Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $22.4M worth of Folic through 5,361 shipments from 693 suppliers to 148 countries, serving 1,433 buyers globally. Gracure Pharmaceuticals Limited contributes $3.0M to this total, accounting for 5.3% of India's Folic exports. Gracure Pharmaceuticals Limited ships Folic to 3 countries through 4 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Folic Exports?
Gracure Pharmaceuticals Limited's average Folic shipment value is $12.6K per consignment, based on 236 shipments totaling $3.0M. The largest destination is BELGIUM (98.2% of Gracure Pharmaceuticals Limited's Folic exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Folic Exporters?
Gracure Pharmaceuticals Limited ranks #2 among 693 Indian Folic exporters with a 5.3% market share. The top 3 exporters are GRACURE PHARMACEUTICALS LIMITED ($3.0M), STRIDES PHARMA SCIENCE LIMITED ($2.8M), CADILA PHARMACEUTICALS LIMITED ($2.6M). Gracure Pharmaceuticals Limited processed 236 shipments to 3 destination countries.
What Folic Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FERCEFOL SYRUP B 150 ML IRON III HYDROXIDE POLYMALTOSE EQ TO 50 MG ELEMENTAL IRON FOLIC ACID 2 MG ASCORBIC ACID 100 M | $201.8K | 5 |
| FERCEFOL SYRUP B 150 ML IRON III HYDROXIDE POLYMALTOSE EQ TO 50 MG ELEMENTAL IRON FOLIC ACID 2 MG ASCORBIC ACID 100 MG | $162.0K | 5 |
| FERCEFOL B 30 TABLETS FERROUS FUMARATEBP 308 MG FOLIC ACID BP 4 MG ASCORBICACID BP 200 MG | $113.7K | 4 |
| FERCEFOL B/30 TABLETS (FERROUS FUMARATEBP 308 MG,FOLIC ACID BP 4 MG,ASCORBIC ACID BP 200 MG) | $111.2K | 5 |
| FERCEFOL B 30 TABLETS FERROUS FUMARATEBP 308 MG FOLIC ACID BP 4 MG ASCORBIC ACID BP 200 MG | $80.1K | 3 |
| FERCEFOL SYRUP B/150ML (IRON(III)HYDROXIDE POLYMALTOSE EQ TO 50 MG ELEMENTAL IRON FOLIC ACID 2MGASCORBIC ACID 100MG)NOS | $77.0K | 6 |
| FERCEFOL SYRUP B/150 ML(IRON (III)HYDROXIDE POLYMALTOSE EQ TO 50MG ELEMENTAL IRON,FOLIC ACID 2MG,ASCORBIC ACID 100MG)NOS | $76.9K | 6 |
| FERCEFOL SYRUP B/150 ML(IRON (III)HYDROXIDE POLYMALTOSE EQ TO 50 MG ELEMENTAL IRON, FOLIC ACID 2MG,ASCORBIC ACID 100MG) | $75.7K | 2 |
| FERCEFOL SYRUP B/150 ML (IRON (III)HYDROXIDE POLYMALTOSE EQ TO 50 MG ELEMENTALIRON,FOLIC ACID 2 MG,ASCORBIC ACID 100MG | $50.7K | 2 |
| FERCEFOL SYRUP B/150MLIRON IIIHYDROXIDE POLYMALTOSE EQ TO 50MG ELEMENTAL IRONFOLIC ACID 2MGASCORBIC ACID 100MG | $50.0K | 1 |
Gracure Pharmaceuticals Limited exports 156 distinct Folic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FERCEFOL SYRUP B 150 ML IRON III HYDROXIDE POLYMALTOSE EQ TO with 5 shipments worth $201.8K.
Regulatory Requirements: Exporting Folic to Key Markets
What Gracure Pharmaceuticals Limited must comply with to export Folic to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Folic Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GRACURE PHARMACEUTICALS LIMITED ★ | $3.0M | 236 | 3 | $12.6K |
| 3 | STRIDES PHARMA SCIENCE LIMITED | $2.8M | 86 | 1 | $32.0K |
| 4 | CADILA PHARMACEUTICALS LIMITED | $2.6M | 103 | 13 | $25.7K |
Gracure Pharmaceuticals Limited ranks #2 among 693 Indian Folic exporters. Average shipment value of $12.6K compared to the market average of $32.3K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and CADILA PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Folic Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 679 | 12.7% |
| JNPT | 390 | 7.3% |
| JNPT/ NHAVA SHEVA SEA | 348 | 6.5% |
| SAHAR AIR | 334 | 6.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 284 | 5.3% |
| MUNDRA SEA | 184 | 3.4% |
| DELHI AIR | 158 | 2.9% |
| PATLI ICD | 153 | 2.9% |
What Other Nutritional Supplements Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these nutritional supplements products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Folic Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Folic, top products include Tramadol, Albendazole, Melatonin, Celecoxib, Doxycycline. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Folic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Folic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 236 individual customs records matching Gracure Pharmaceuticals Limited exporting Folic, covering 156 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 1,433+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Folic Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Folic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Folic Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Folic. For current shipment-level data, contact TransData Nexus.